Richard Jacinto II 13D and 13G filings for DiaMedica Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 5:30 pm Purchase | 2025-09-30 | 13G | DiaMedica Therapeutics Inc. DMAC | Richard Jacinto II | 4,958,823 9.600% | 400,000 (+8.77%) | Filing |
| 2023-06-23 5:13 pm Purchase | 2023-06-23 | 13G | DiaMedica Therapeutics Inc. DMAC | Richard Jacinto II | 4,558,823 12.000% | 2,058,823 (+82.35%) | Filing |
| 2023-01-13 4:46 pm Purchase | 2022-12-31 | 13G | DiaMedica Therapeutics Inc. DMAC | Richard Jacinto II | 2,500,000 9.500% | 850,947 (+51.60%) | Filing |
| 2022-05-27 4:44 pm Purchase | 2022-04-20 | 13G | DiaMedica Therapeutics Inc. DMAC | Richard Jacinto II | 1,649,053 6.200% | 1,649,053 (New Position) | Filing |